Related Experiment Videos

[MRI with oral filling in patients with chronic inflammatory bowel diseases]

C Born1, B Nagel, G Leinsinger

  • 1Institut für Klinische Radiologie/Innenstadt, Klinikum der Universität München, Munich. christine.born@radin.med.uni-muenchen.de

Der Radiologe
|January 29, 2003
PubMed
Abstract

Insights

Mannitol-enhanced MRI is a valuable tool for diagnosing Crohn's disease (CD), showing high diagnostic accuracy despite some limitations in bowel distension.

Area of Science:

  • Gastroenterology
  • Radiology
  • Medical Imaging

Background:

  • Crohn's disease (CD) diagnosis requires accurate imaging.
  • Optimizing MRI protocols for CD assessment is crucial.

Purpose of the Study:

  • To evaluate the efficacy of mannitol-enhanced MRI in diagnosing Crohn's disease.
  • Assess image quality and diagnostic yield of this technique.

Main Methods:

  • 75 patients with suspected or established CD underwent MRI.
  • Oral mannitol solution and rectal filling were used for bowel distension.
  • T1-weighted sequences before and after contrast administration, plus dynamic imaging, were performed.

Main Results:

  • Diagnostic assessment was possible in most cases, with 69% showing CD-indicative alterations.
  • Significant signal increase in thickened bowel walls (p=0.001).
  • Detected stenoses (56%), fistulas (23%), and an abscess (1 patient).

Conclusions:

  • Mannitol-MRI is a valuable method for diagnosing inflammatory bowel disease.
  • Further improvements in distal bowel distension are recommended.
  • High patient acceptance and diagnostic value support its use.

Related Concept Videos